1
1 of 4
- Yale Physicians Building800 Howard AvenueNew Haven, CT 06519
- Yale Heart and Vascular Institute4a Devine StreetNorth Haven, CT 06473
- Yale Heart and Vascular Center - Heart FailureLawrence + Memorial Medical Office Building194 Howard StreetNew London, CT 06320
- Yale Heart and Vascular CenterWawecus Medical Center79 Wawecus StreetNorwich, CT 06360
Sara Tabtabai
she/her/hers
Cardiovascular Medicine, Heart Failure
Telehealth is available
Patient type treated
Adult
Accepting new patients
Yes
Referral required
From patients or physicians
Biography
Sara Tabtabai, MD, is a cardiologist who specializes in heart failure and cardiovascular medicine. She diagnoses and treats conditions related to advanced heart failure, women's heart disease, cardio-obstetrics, and amyloid cardiomyopathy (where abnormal proteins accumulate in the heart muscle, leading to damage and impaired heart function).
As an assistant professor at Yale School of Medicine, Dr. Tabtabai is involved in research aimed at enhancing the understanding and treatment of heart failure.
Dr. Tabtabai earned her medical degree at the University of Connecticut School of Medicine. She then completed residency and fellowship training in internal and cardiovascular medicine, as well as advanced training in heart failure and transplantation, at Massachusetts General Hospital.
Titles
- Assistant Professor
Education & Training
- Advanced Heart Failure and Transplantation FellowMassachusetts General Hospital (2016)
- FellowMassachusetts General Hospital (2015)
- ResidentMassachusetts General Hospital (2012)
- MDUniversity of Connecticut School of Medicine (2009)
Additional Information
Honors & Recognitions
- Govenor of the Connecticut Chapter of the American College of Cardiology: The American College of Cardiology (2026)
- Excellence in Teaching Award: University of Connecticut School of Medicine, Cardiovascular Medicine Fellowship Program (2023)
- Fellow of the American College of Cardiology: The American College of Cardiology (2021)
- Fellow of the American College of Cardiology: American College of Cardiology (2020)
Professional Service
- Connecticut Chapter of the American College of Cardiology (2026 - Present): Elected to serve as the Governor of the Connecticut Chapter of the American Cardiology, Governor elect year 2025, Governor Term 2026 to 2029
- Connecticut Chapter of the American College of Cardiology Education Committee (2023 - Present): Chair
- Cardiovascular Medicine Network Development Working Group (2023 - Present): Acting Co-Chair
- Frontiers in Cardiovascular Medicine (2023 - Present): Early-Career Mentored Editorial Board Member
- HFSAP Question Writing Committee (2020 - Present): Member
- The American College of Cardiology (2020 - Present): Fellow
- Connecticut Chapter of the American College of Cardiology (2020 - Present): Council Member
- The Journal of the American College of Cardiology (2018 - Present): Ad-hoc mentored reviewer
Publications
- Ahmad T, Desai NR, Tabtabai S. Cardiovascular Care in the United States: Penny Wise and Pound Foolish. J Am Coll Cardiol 2024, 84: 694-695. PMID: 39142722, DOI: 10.1016/j.jacc.2024.07.001.
- Gooding K, Pillai A, Tabtabai S. WHEN ALTERNATIVE HEALTH CLINICS GO WRONG; STRONG MUSCLES, WEAK HEART AND A CASE OF ANABOLIC STEROID ASSOCIATED CARDIOMYOPATHY. Journal Of The American College Of Cardiology 2024, 83: 3240. DOI: 10.1016/s0735-1097(24)05230-6.
- Kim M, Aseltine R, Tabtabai S. Understanding the Burden of 30-Day Readmission in Patients With Both Primary and Secondary Diagnoses of Heart Failure: Causes, Timing, and Impact of Co-Morbidities. The American Journal Of Cardiology 2023, 210: 76-84. PMID: 37858595, DOI: 10.1016/j.amjcard.2023.09.086.
- Kim M, Tabtabai S, Aseltine R. Predictors of 30-Day Readmission in Patients Hospitalized With Heart Failure as a Primary Versus Secondary Diagnosis. The American Journal Of Cardiology 2023, 207: 407-417. PMID: 37782972, DOI: 10.1016/j.amjcard.2023.08.111.
- Adeel M, Wakefield D, Soucier R, ZuWallack R, Tabtabai S. The Presence Of Clinical COPD Predicts Mortality In Heart Failure Patient Population. Journal Of Cardiac Failure 2023, 29: 643. DOI: 10.1016/j.cardfail.2022.10.237.
- Predicting 30-day Readmission In Patients With A Primary Versus Secondary Diagnosis Of Heart FailureKim M, Aseltine R, Tabtabai S. Predicting 30-day Readmission In Patients With A Primary Versus Secondary Diagnosis Of Heart Failure. Journal Of Cardiac Failure 2023, 29: 681. DOI: 10.1016/j.cardfail.2022.10.335.
- Kim M, Aseltine R, Tabtabai S. Readmission Patterns In Patients Admitted With Primary Or Secondary Diagnosis Of Heart Failure. Journal Of Cardiac Failure 2023, 29: 682. DOI: 10.1016/j.cardfail.2022.10.337.
- Mentz R, Anstrom K, Eisenstein E, Sapp S, Greene S, Morgan S, Testani J, Harrington A, Sachdev V, Ketema F, Kim D, Desvigne-Nickens P, Pitt B, Velazquez E, Adams K, Bhatt K, DeWald T, Axsom K, Murthy S, Rich J, Testani J, Smith B, Vader J, McCulloch M, Skopicki H, Psotka M, Heroux A, Lala-Trindade A, Stevens G, Tang W, Lev Y, William P, Eberly A, Gottleib S, Haught W, Grafton G, Larned J, Tejwani L, Mody F, Krim S, Robinson M, Fang J, Adler A, Bell A, Banerjee D, Ruiz Duque E, Mizyed A, Rommel J, Arhinful J, Goyal P, Hall M, Hummel S, Shetty S, Haas D, Vilaro J, Alexy T, Herre J, Clark J, Ambrosy A, Gaglianello N, Ramasubbu K, Meadows J, Tabtabai S, Sherwood M, Hasni S, D'Urso M, Muneer B, Dunlap S, Davis W, Friedman D, Guglin M, Ferguson A, Abbate A, Smart F. Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure. JAMA 2023, 329: 214-223. PMID: 36648467, PMCID: PMC9857435, DOI: 10.1001/jama.2022.23924.
- Amann D, Akdogan R, Kaur A, ZuWallack R, Wakefield D, Tabtabai S. The Effect of COPD Co-Morbidity on Mortality in CHF. 2022, a4021-a4021. DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4021.
- Esstman B, Cyr P, Wakefield D, Soucier R, Tabtabai S. Early Palliative Care Consultation Reduces Length Of Stay And Cost In Patients Hospitalized With Acute Decompensated Heart Failure. Journal Of Cardiac Failure 2022, 28: s39-s40. DOI: 10.1016/j.cardfail.2022.03.106.
- Tiu J, Balakumaran K, Barry M, Cipriani K, Kearney L, Oranefo J, Kim M, Tabtabai S. A Dedicated Guideline Directed Medical Therapy Clinic Improves Quality of Care and Outcomes In Patients with Heart Failure and Reduced Ejection Fraction. Journal Of Cardiac Failure 2020, 26: s133. DOI: 10.1016/j.cardfail.2020.09.386.
- Krishnan A, Tandon V, Ramanathan R, Mukarram O, Tabtabai S, Balakumaran K. RACIAL DISPARITIES IN WOMEN ADMITTED WITH PERIPARTUM CARDIOMYOPATHY: NIS DATABASE ANALYSIS. CHEST Journal 2019, 156: a1130. DOI: 10.1016/j.chest.2019.08.1032.
- Balakumaran K, Baker W, Tandon V, Joshi S, Tabtabai S, Jaiswal A. Characteristics of Elderly Listed for Heart Transplantation: An Analysis of the Scientific Registry of Transplant Recipients. Journal Of Cardiac Failure 2019, 25: s15. DOI: 10.1016/j.cardfail.2019.07.046.
- Balakumaran K, Goldgrab D, Krishnan A, Shah N, Kim M, Rabieihashemi S, Cipriani K, Pickett C, Tabtabai S. Achievement of Target Doses of Guideline-Directed Medical Therapy Prior to Cardiac Resynchronization Therapy is Suboptimal. Journal Of Cardiac Failure 2019, 25: s128. DOI: 10.1016/j.cardfail.2019.07.366.
- Sharma T, Tigadi S, Khurana A, Tabtabai S. CLINICAL OVERLAP BETWEEN MYOPERICARDITIS AND STRESS INDUCED CARDIOMYOPATHY: A DIAGNOSTIC AND THERAPEUTIC CHALLENGE. Journal Of The American College Of Cardiology 2019, 73: 2586. DOI: 10.1016/s0735-1097(19)33192-4.
- Sharma T, Tigadi S, Baldwin J, Tabtabai S. Clinical Overlap Between Myopericarditis and Stress Induced Cardiomyopathy: A Diagnostic and Therapeutic Challenge. American Journal Of Case Reports 2019, 20: 252-257. PMID: 30804319, PMCID: PMC6402271, DOI: 10.12659/ajcr.912169.
- Goldgrab D, Balakumaran K, Kim M, Tabtabai S. Updates in heart failure 30-day readmission prevention. Heart Failure Reviews 2018, 24: 177-187. PMID: 30488242, DOI: 10.1007/s10741-018-9754-4.
- Yeh D, Schmidt A, Eisman A, Serfas J, Naqvi M, Youniss M, Ryfa A, Khan A, Safi L, Tabtabai S, Bhatt A, Lewis G. Impaired right ventricular reserve predicts adverse cardiac outcomes in adults with congenital right heart disease. Heart 2018, 104: 2044. PMID: 30030334, DOI: 10.1136/heartjnl-2017-312572.
- Nasir U, Balakumaran K, Tabtabai S, Pickett C, Meng J. Sick sinus syndrome in cardiac noncompaction. HeartRhythm Case Reports 2018, 4: 359-361. PMID: 30112287, PMCID: PMC6092599, DOI: 10.1016/j.hrcr.2018.05.001.
- Murton O, Hillman R, Mehta D, Semigran M, Daher M, Cunningham T, Verkouw K, Tabtabai S, Steiner J, Dec G, Ausiello D. Acoustic speech analysis of patients with decompensated heart failure: A pilot study. The Journal Of The Acoustical Society Of America 2017, 142: el401-el407. PMID: 29092550, PMCID: PMC5724620, DOI: 10.1121/1.5007092.
- Murton O, Daher M, Cunningham T, Verkouw K, Tabtabai S, Steiner J, Hillman R, Dec G, Ausiello D, Mehta D. Acoustic speech analysis of patients with decompensated heart failure: A pilot study. The Journal Of The Acoustical Society Of America 2017, 142: 2639-2640. DOI: 10.1121/1.5014673.
- Schmidt A, Yeh D, Tabtabai S, Kennedy K, Yeh R, Bhatt A. National Trends in Hospitalizations of Adults With Tetralogy of Fallot. The American Journal Of Cardiology 2016, 118: 906-911. PMID: 27530825, PMCID: PMC5349299, DOI: 10.1016/j.amjcard.2016.06.034.
- Tabtabai S, Yeh D, Stefanescu A, Kennedy K, Yeh R, Bhatt A. National Trends in Hospitalizations for Patients With Single-Ventricle Anatomy. The American Journal Of Cardiology 2015, 116: 773-778. PMID: 26100589, DOI: 10.1016/j.amjcard.2015.05.053.
- Tabtabai S, Steiner J, Vaduganathan M, Stone J, Estep J, Witteles R, Giuseppe F, Zucker M, Baran D, Seldin D, Patel J, Hanna M, Cordero-Reyes A, Selby V, Maurer M, Semigran M. (241) The Use of Circulatory Support While Awaiting Heart Transplant in Patients With AL and TTR: Amyloidosis: A Report From iCCAT, the International Consortium for Cardiac Amyloid Transplant. The Journal Of Heart And Lung Transplantation 2015, 34: s95-s96. DOI: 10.1016/j.healun.2015.01.254.
- Vaduganathan M, Tabtabai S, Steiner J, Stone J, Estep J, Witteles R, Feltrin G, Zucker M, Baran D, Seldin D, Patel J, Hanna M, Cordero-Reyes A, Selby V, Semigran M, Maurer M. (801) Modified BMI Does Not Predict Adverse Outcomes in Patients With Cardiac Amyloid Undergoing Heart Transplantation: A Report From iCCAT (International Consortium for Cardiac Amyloid Transplantation). The Journal Of Heart And Lung Transplantation 2015, 34: s292-s293. DOI: 10.1016/j.healun.2015.01.820.
- Tabtabai S, Vaduganathan M, Steiner J, Stone J, Estep J, Witteles R, Feltrin G, Zucker M, Baran D, Seldin D, Patel J, Hanna M, Cordero-Reyes A, Selby V, Semigran M, Maurer M. MODIFIED BMI DOES NOT PREDICT ADVERSE OUTCOMES IN PATIENTS WITH CARDIAC AMYLOID UNDERGOING HEART TRANSPLANTATION: A REPORT FROM ICCAT (INTERNATIONAL CONSORTIUM FOR CARDIAC AMYLOID TRANSPLANTATION). Journal Of The American College Of Cardiology 2015, 65: a943. DOI: 10.1016/s0735-1097(15)60943-3.
- Stefanescu A, Bhatt A, Serfas J, Tabtabai S, Ruff J, Yeh D. POOR RIGHT VENTRICULAR EXERCISE RESERVE PREDICTS HEART FAILURE AND ARRHYTHMIA IN ADULTS WITH CONGENITAL RIGHT HEART DISEASE. Journal Of The American College Of Cardiology 2015, 65: a563. DOI: 10.1016/s0735-1097(15)60563-0.
- Upadhyay G, Chatterjee N, Kandala J, Friedman D, Park M, Tabtabai S, Hung J, Singh J. Assessing mitral regurgitation in the prediction of clinical outcome after cardiac resynchronization therapy. Heart Rhythm 2015, 12: 1201-1208. PMID: 25708879, DOI: 10.1016/j.hrthm.2015.02.022.
- Tabtabai S, Beckman J. Thromboangiitis Obliterans. 2015, 3031-3041. DOI: 10.1007/978-3-642-37078-6_114.
- Tabtabai S, Beckman J. Thromboangiitis Obliterans (Buerger’s Disease). 2014, 1-12. DOI: 10.1007/978-3-642-37393-0_114-1.
- Niehaus E, Tabtabai S, Sarswat N, Stone J, Gilstrap L, Maurer M, Witteles R, Estep J, Baran D, Zucker M, Feltrin G, Seldin D, Semigran M. NEED FOR RENAL REPLACEMENT THERAPY AFTER CARDIAC TRANSPLANTATION IN PATIENTS WITH AL AMYLOIDOSIS IS ASSOCIATED WITH POOR SURVIVAL. Journal Of The American College Of Cardiology 2014, 63: a895. DOI: 10.1016/s0735-1097(14)60895-0.
- Tabtabai S, Niehaus E, Sarswat N, Stone J, Gilstrap L, Maurer M, Witteles R, Estep J, Baran D, Zucker M, Feltrin G, Seldin D, Semigran M. (125) Reduced Survival in Lambda Predominant Cardiac AL Amyloidosis Patients Awaiting Heart Transplant. The Journal Of Heart And Lung Transplantation 2014, 33: s52. DOI: 10.1016/j.healun.2014.01.172.
- Tabtabai S, Niehaus E, Sarswat N, Stone J, Maurer M, Witteles R, Estep J, Baran D, Zucker M, Feltrin G, Seldin D, Semigran M. REDUCED SURVIVAL IN LAMBDA PREDOMINANT CARDIAC AL AMYLOIDOSIS PATIENTS AWAITING ORTHOTOPIC HEART TRANSPLANT. Journal Of The American College Of Cardiology 2014, 63: a930. DOI: 10.1016/s0735-1097(14)60930-x.
- Sarswat N, Niehaus E, Tabtabai S, Stone J, Gilstrap L, Mauer M, Witteles R, Estep J, Baran D, Zucker M, Guiseppe F, Seldin D, Semigran M. (124) Pre-transplant Chemotherapy Does Not Affect Cardiac Transplant Survival in Light-Chain Amyloid Patients. The Journal Of Heart And Lung Transplantation 2014, 33: s51-s52. DOI: 10.1016/j.healun.2014.01.171.
- Niehaus E, Tabtabai S, Sarswat N, Stone J, Gilstrap L, Maurer M, Witteles R, Estep J, Baran D, Zucker M, Feltrin G, Seldin D, Semigran M. (236) Need for Renal Replacement Therapy after Cardiac Transplantation in Patients with AL Amyloidosis Is Associated with Poor Survival. The Journal Of Heart And Lung Transplantation 2014, 33: s91-s92. DOI: 10.1016/j.healun.2014.01.280.
- Sarswat N, Niehaus E, Tabtabai S, Stone J, Gilstrap L, Maurer M, Witteles R, Estep J, Baran D, Zucker M, Seldin D, Semigran M. PRE-TRANSPLANT CHEMOTHERAPY DOES NOT AFFECT POST TRANSPLANT OUTCOME IN PATIENTS UNDERGOING OHT FOR AL CARDIOMYOPATHY. Journal Of The American College Of Cardiology 2014, 63: a884. DOI: 10.1016/s0735-1097(14)60884-6.
- Saini H, Tabtabai S, Stone J, Ellinor P. Chapter 6 Pathophysiology of Cardiomyopathies. 2014, 101-119. DOI: 10.1016/b978-0-12-405206-2.00006-5.
- Tabtabai S, Danielian A, Bernstein B, Arora S, Soucier R. The Impact of a Multidisciplinary Approach in the Management of Patients with Acute Decompensated Heart Failure. Journal Of Cardiac Failure 2009, 15: s118. DOI: 10.1016/j.cardfail.2009.06.051.
Departments and Programs
Locations
1
1 of 4
- Yale Physicians Building800 Howard AvenueNew Haven, CT 06519
- Yale Heart and Vascular Institute4a Devine StreetNorth Haven, CT 06473
- Yale Heart and Vascular Center - Heart FailureLawrence + Memorial Medical Office Building194 Howard StreetNew London, CT 06320
- Yale Heart and Vascular CenterWawecus Medical Center79 Wawecus StreetNorwich, CT 06360
Biography
Sara Tabtabai, MD, is a cardiologist who specializes in heart failure and cardiovascular medicine. She diagnoses and treats conditions related to advanced heart failure, women's heart disease, cardio-obstetrics, and amyloid cardiomyopathy (where abnormal proteins accumulate in the heart muscle, leading to damage and impaired heart function).
As an assistant professor at Yale School of Medicine, Dr. Tabtabai is involved in research aimed at enhancing the understanding and treatment of heart failure.
Dr. Tabtabai earned her medical degree at the University of Connecticut School of Medicine. She then completed residency and fellowship training in internal and cardiovascular medicine, as well as advanced training in heart failure and transplantation, at Massachusetts General Hospital.
Titles
- Assistant Professor
Education & Training
- Advanced Heart Failure and Transplantation FellowMassachusetts General Hospital (2016)
- FellowMassachusetts General Hospital (2015)
- ResidentMassachusetts General Hospital (2012)
- MDUniversity of Connecticut School of Medicine (2009)
Additional Information
Honors & Recognitions
- Govenor of the Connecticut Chapter of the American College of Cardiology: The American College of Cardiology (2026)
- Excellence in Teaching Award: University of Connecticut School of Medicine, Cardiovascular Medicine Fellowship Program (2023)
- Fellow of the American College of Cardiology: The American College of Cardiology (2021)
- Fellow of the American College of Cardiology: American College of Cardiology (2020)
Professional Service
- Connecticut Chapter of the American College of Cardiology (2026 - Present): Elected to serve as the Governor of the Connecticut Chapter of the American Cardiology, Governor elect year 2025, Governor Term 2026 to 2029
- Connecticut Chapter of the American College of Cardiology Education Committee (2023 - Present): Chair
- Cardiovascular Medicine Network Development Working Group (2023 - Present): Acting Co-Chair
- Frontiers in Cardiovascular Medicine (2023 - Present): Early-Career Mentored Editorial Board Member
- HFSAP Question Writing Committee (2020 - Present): Member
- The American College of Cardiology (2020 - Present): Fellow
- Connecticut Chapter of the American College of Cardiology (2020 - Present): Council Member
- The Journal of the American College of Cardiology (2018 - Present): Ad-hoc mentored reviewer
Publications
- Ahmad T, Desai NR, Tabtabai S. Cardiovascular Care in the United States: Penny Wise and Pound Foolish. J Am Coll Cardiol 2024, 84: 694-695. PMID: 39142722, DOI: 10.1016/j.jacc.2024.07.001.
- Gooding K, Pillai A, Tabtabai S. WHEN ALTERNATIVE HEALTH CLINICS GO WRONG; STRONG MUSCLES, WEAK HEART AND A CASE OF ANABOLIC STEROID ASSOCIATED CARDIOMYOPATHY. Journal Of The American College Of Cardiology 2024, 83: 3240. DOI: 10.1016/s0735-1097(24)05230-6.
- Kim M, Aseltine R, Tabtabai S. Understanding the Burden of 30-Day Readmission in Patients With Both Primary and Secondary Diagnoses of Heart Failure: Causes, Timing, and Impact of Co-Morbidities. The American Journal Of Cardiology 2023, 210: 76-84. PMID: 37858595, DOI: 10.1016/j.amjcard.2023.09.086.
- Kim M, Tabtabai S, Aseltine R. Predictors of 30-Day Readmission in Patients Hospitalized With Heart Failure as a Primary Versus Secondary Diagnosis. The American Journal Of Cardiology 2023, 207: 407-417. PMID: 37782972, DOI: 10.1016/j.amjcard.2023.08.111.
- Adeel M, Wakefield D, Soucier R, ZuWallack R, Tabtabai S. The Presence Of Clinical COPD Predicts Mortality In Heart Failure Patient Population. Journal Of Cardiac Failure 2023, 29: 643. DOI: 10.1016/j.cardfail.2022.10.237.
- Predicting 30-day Readmission In Patients With A Primary Versus Secondary Diagnosis Of Heart FailureKim M, Aseltine R, Tabtabai S. Predicting 30-day Readmission In Patients With A Primary Versus Secondary Diagnosis Of Heart Failure. Journal Of Cardiac Failure 2023, 29: 681. DOI: 10.1016/j.cardfail.2022.10.335.
- Kim M, Aseltine R, Tabtabai S. Readmission Patterns In Patients Admitted With Primary Or Secondary Diagnosis Of Heart Failure. Journal Of Cardiac Failure 2023, 29: 682. DOI: 10.1016/j.cardfail.2022.10.337.
- Mentz R, Anstrom K, Eisenstein E, Sapp S, Greene S, Morgan S, Testani J, Harrington A, Sachdev V, Ketema F, Kim D, Desvigne-Nickens P, Pitt B, Velazquez E, Adams K, Bhatt K, DeWald T, Axsom K, Murthy S, Rich J, Testani J, Smith B, Vader J, McCulloch M, Skopicki H, Psotka M, Heroux A, Lala-Trindade A, Stevens G, Tang W, Lev Y, William P, Eberly A, Gottleib S, Haught W, Grafton G, Larned J, Tejwani L, Mody F, Krim S, Robinson M, Fang J, Adler A, Bell A, Banerjee D, Ruiz Duque E, Mizyed A, Rommel J, Arhinful J, Goyal P, Hall M, Hummel S, Shetty S, Haas D, Vilaro J, Alexy T, Herre J, Clark J, Ambrosy A, Gaglianello N, Ramasubbu K, Meadows J, Tabtabai S, Sherwood M, Hasni S, D'Urso M, Muneer B, Dunlap S, Davis W, Friedman D, Guglin M, Ferguson A, Abbate A, Smart F. Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure. JAMA 2023, 329: 214-223. PMID: 36648467, PMCID: PMC9857435, DOI: 10.1001/jama.2022.23924.
- Amann D, Akdogan R, Kaur A, ZuWallack R, Wakefield D, Tabtabai S. The Effect of COPD Co-Morbidity on Mortality in CHF. 2022, a4021-a4021. DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4021.
- Esstman B, Cyr P, Wakefield D, Soucier R, Tabtabai S. Early Palliative Care Consultation Reduces Length Of Stay And Cost In Patients Hospitalized With Acute Decompensated Heart Failure. Journal Of Cardiac Failure 2022, 28: s39-s40. DOI: 10.1016/j.cardfail.2022.03.106.
- Tiu J, Balakumaran K, Barry M, Cipriani K, Kearney L, Oranefo J, Kim M, Tabtabai S. A Dedicated Guideline Directed Medical Therapy Clinic Improves Quality of Care and Outcomes In Patients with Heart Failure and Reduced Ejection Fraction. Journal Of Cardiac Failure 2020, 26: s133. DOI: 10.1016/j.cardfail.2020.09.386.
- Krishnan A, Tandon V, Ramanathan R, Mukarram O, Tabtabai S, Balakumaran K. RACIAL DISPARITIES IN WOMEN ADMITTED WITH PERIPARTUM CARDIOMYOPATHY: NIS DATABASE ANALYSIS. CHEST Journal 2019, 156: a1130. DOI: 10.1016/j.chest.2019.08.1032.
- Balakumaran K, Baker W, Tandon V, Joshi S, Tabtabai S, Jaiswal A. Characteristics of Elderly Listed for Heart Transplantation: An Analysis of the Scientific Registry of Transplant Recipients. Journal Of Cardiac Failure 2019, 25: s15. DOI: 10.1016/j.cardfail.2019.07.046.
- Balakumaran K, Goldgrab D, Krishnan A, Shah N, Kim M, Rabieihashemi S, Cipriani K, Pickett C, Tabtabai S. Achievement of Target Doses of Guideline-Directed Medical Therapy Prior to Cardiac Resynchronization Therapy is Suboptimal. Journal Of Cardiac Failure 2019, 25: s128. DOI: 10.1016/j.cardfail.2019.07.366.
- Sharma T, Tigadi S, Khurana A, Tabtabai S. CLINICAL OVERLAP BETWEEN MYOPERICARDITIS AND STRESS INDUCED CARDIOMYOPATHY: A DIAGNOSTIC AND THERAPEUTIC CHALLENGE. Journal Of The American College Of Cardiology 2019, 73: 2586. DOI: 10.1016/s0735-1097(19)33192-4.
- Sharma T, Tigadi S, Baldwin J, Tabtabai S. Clinical Overlap Between Myopericarditis and Stress Induced Cardiomyopathy: A Diagnostic and Therapeutic Challenge. American Journal Of Case Reports 2019, 20: 252-257. PMID: 30804319, PMCID: PMC6402271, DOI: 10.12659/ajcr.912169.
- Goldgrab D, Balakumaran K, Kim M, Tabtabai S. Updates in heart failure 30-day readmission prevention. Heart Failure Reviews 2018, 24: 177-187. PMID: 30488242, DOI: 10.1007/s10741-018-9754-4.
- Yeh D, Schmidt A, Eisman A, Serfas J, Naqvi M, Youniss M, Ryfa A, Khan A, Safi L, Tabtabai S, Bhatt A, Lewis G. Impaired right ventricular reserve predicts adverse cardiac outcomes in adults with congenital right heart disease. Heart 2018, 104: 2044. PMID: 30030334, DOI: 10.1136/heartjnl-2017-312572.
- Nasir U, Balakumaran K, Tabtabai S, Pickett C, Meng J. Sick sinus syndrome in cardiac noncompaction. HeartRhythm Case Reports 2018, 4: 359-361. PMID: 30112287, PMCID: PMC6092599, DOI: 10.1016/j.hrcr.2018.05.001.
- Murton O, Hillman R, Mehta D, Semigran M, Daher M, Cunningham T, Verkouw K, Tabtabai S, Steiner J, Dec G, Ausiello D. Acoustic speech analysis of patients with decompensated heart failure: A pilot study. The Journal Of The Acoustical Society Of America 2017, 142: el401-el407. PMID: 29092550, PMCID: PMC5724620, DOI: 10.1121/1.5007092.
- Murton O, Daher M, Cunningham T, Verkouw K, Tabtabai S, Steiner J, Hillman R, Dec G, Ausiello D, Mehta D. Acoustic speech analysis of patients with decompensated heart failure: A pilot study. The Journal Of The Acoustical Society Of America 2017, 142: 2639-2640. DOI: 10.1121/1.5014673.
- Schmidt A, Yeh D, Tabtabai S, Kennedy K, Yeh R, Bhatt A. National Trends in Hospitalizations of Adults With Tetralogy of Fallot. The American Journal Of Cardiology 2016, 118: 906-911. PMID: 27530825, PMCID: PMC5349299, DOI: 10.1016/j.amjcard.2016.06.034.
- Tabtabai S, Yeh D, Stefanescu A, Kennedy K, Yeh R, Bhatt A. National Trends in Hospitalizations for Patients With Single-Ventricle Anatomy. The American Journal Of Cardiology 2015, 116: 773-778. PMID: 26100589, DOI: 10.1016/j.amjcard.2015.05.053.
- Tabtabai S, Steiner J, Vaduganathan M, Stone J, Estep J, Witteles R, Giuseppe F, Zucker M, Baran D, Seldin D, Patel J, Hanna M, Cordero-Reyes A, Selby V, Maurer M, Semigran M. (241) The Use of Circulatory Support While Awaiting Heart Transplant in Patients With AL and TTR: Amyloidosis: A Report From iCCAT, the International Consortium for Cardiac Amyloid Transplant. The Journal Of Heart And Lung Transplantation 2015, 34: s95-s96. DOI: 10.1016/j.healun.2015.01.254.
- Vaduganathan M, Tabtabai S, Steiner J, Stone J, Estep J, Witteles R, Feltrin G, Zucker M, Baran D, Seldin D, Patel J, Hanna M, Cordero-Reyes A, Selby V, Semigran M, Maurer M. (801) Modified BMI Does Not Predict Adverse Outcomes in Patients With Cardiac Amyloid Undergoing Heart Transplantation: A Report From iCCAT (International Consortium for Cardiac Amyloid Transplantation). The Journal Of Heart And Lung Transplantation 2015, 34: s292-s293. DOI: 10.1016/j.healun.2015.01.820.
- Tabtabai S, Vaduganathan M, Steiner J, Stone J, Estep J, Witteles R, Feltrin G, Zucker M, Baran D, Seldin D, Patel J, Hanna M, Cordero-Reyes A, Selby V, Semigran M, Maurer M. MODIFIED BMI DOES NOT PREDICT ADVERSE OUTCOMES IN PATIENTS WITH CARDIAC AMYLOID UNDERGOING HEART TRANSPLANTATION: A REPORT FROM ICCAT (INTERNATIONAL CONSORTIUM FOR CARDIAC AMYLOID TRANSPLANTATION). Journal Of The American College Of Cardiology 2015, 65: a943. DOI: 10.1016/s0735-1097(15)60943-3.
- Stefanescu A, Bhatt A, Serfas J, Tabtabai S, Ruff J, Yeh D. POOR RIGHT VENTRICULAR EXERCISE RESERVE PREDICTS HEART FAILURE AND ARRHYTHMIA IN ADULTS WITH CONGENITAL RIGHT HEART DISEASE. Journal Of The American College Of Cardiology 2015, 65: a563. DOI: 10.1016/s0735-1097(15)60563-0.
- Upadhyay G, Chatterjee N, Kandala J, Friedman D, Park M, Tabtabai S, Hung J, Singh J. Assessing mitral regurgitation in the prediction of clinical outcome after cardiac resynchronization therapy. Heart Rhythm 2015, 12: 1201-1208. PMID: 25708879, DOI: 10.1016/j.hrthm.2015.02.022.
- Tabtabai S, Beckman J. Thromboangiitis Obliterans. 2015, 3031-3041. DOI: 10.1007/978-3-642-37078-6_114.
- Tabtabai S, Beckman J. Thromboangiitis Obliterans (Buerger’s Disease). 2014, 1-12. DOI: 10.1007/978-3-642-37393-0_114-1.
- Niehaus E, Tabtabai S, Sarswat N, Stone J, Gilstrap L, Maurer M, Witteles R, Estep J, Baran D, Zucker M, Feltrin G, Seldin D, Semigran M. NEED FOR RENAL REPLACEMENT THERAPY AFTER CARDIAC TRANSPLANTATION IN PATIENTS WITH AL AMYLOIDOSIS IS ASSOCIATED WITH POOR SURVIVAL. Journal Of The American College Of Cardiology 2014, 63: a895. DOI: 10.1016/s0735-1097(14)60895-0.
- Tabtabai S, Niehaus E, Sarswat N, Stone J, Gilstrap L, Maurer M, Witteles R, Estep J, Baran D, Zucker M, Feltrin G, Seldin D, Semigran M. (125) Reduced Survival in Lambda Predominant Cardiac AL Amyloidosis Patients Awaiting Heart Transplant. The Journal Of Heart And Lung Transplantation 2014, 33: s52. DOI: 10.1016/j.healun.2014.01.172.
- Tabtabai S, Niehaus E, Sarswat N, Stone J, Maurer M, Witteles R, Estep J, Baran D, Zucker M, Feltrin G, Seldin D, Semigran M. REDUCED SURVIVAL IN LAMBDA PREDOMINANT CARDIAC AL AMYLOIDOSIS PATIENTS AWAITING ORTHOTOPIC HEART TRANSPLANT. Journal Of The American College Of Cardiology 2014, 63: a930. DOI: 10.1016/s0735-1097(14)60930-x.
- Sarswat N, Niehaus E, Tabtabai S, Stone J, Gilstrap L, Mauer M, Witteles R, Estep J, Baran D, Zucker M, Guiseppe F, Seldin D, Semigran M. (124) Pre-transplant Chemotherapy Does Not Affect Cardiac Transplant Survival in Light-Chain Amyloid Patients. The Journal Of Heart And Lung Transplantation 2014, 33: s51-s52. DOI: 10.1016/j.healun.2014.01.171.
- Niehaus E, Tabtabai S, Sarswat N, Stone J, Gilstrap L, Maurer M, Witteles R, Estep J, Baran D, Zucker M, Feltrin G, Seldin D, Semigran M. (236) Need for Renal Replacement Therapy after Cardiac Transplantation in Patients with AL Amyloidosis Is Associated with Poor Survival. The Journal Of Heart And Lung Transplantation 2014, 33: s91-s92. DOI: 10.1016/j.healun.2014.01.280.
- Sarswat N, Niehaus E, Tabtabai S, Stone J, Gilstrap L, Maurer M, Witteles R, Estep J, Baran D, Zucker M, Seldin D, Semigran M. PRE-TRANSPLANT CHEMOTHERAPY DOES NOT AFFECT POST TRANSPLANT OUTCOME IN PATIENTS UNDERGOING OHT FOR AL CARDIOMYOPATHY. Journal Of The American College Of Cardiology 2014, 63: a884. DOI: 10.1016/s0735-1097(14)60884-6.
- Saini H, Tabtabai S, Stone J, Ellinor P. Chapter 6 Pathophysiology of Cardiomyopathies. 2014, 101-119. DOI: 10.1016/b978-0-12-405206-2.00006-5.
- Tabtabai S, Danielian A, Bernstein B, Arora S, Soucier R. The Impact of a Multidisciplinary Approach in the Management of Patients with Acute Decompensated Heart Failure. Journal Of Cardiac Failure 2009, 15: s118. DOI: 10.1016/j.cardfail.2009.06.051.
Departments and Programs
Locations
1
1 of 4
- Yale Physicians Building800 Howard AvenueNew Haven, CT 06519
- Yale Heart and Vascular Institute4a Devine StreetNorth Haven, CT 06473
- Yale Heart and Vascular Center - Heart FailureLawrence + Memorial Medical Office Building194 Howard StreetNew London, CT 06320
- Yale Heart and Vascular CenterWawecus Medical Center79 Wawecus StreetNorwich, CT 06360
1
1 of 4
- Yale Physicians Building800 Howard AvenueNew Haven, CT 06519
- Yale Heart and Vascular Institute4a Devine StreetNorth Haven, CT 06473
- Yale Heart and Vascular Center - Heart FailureLawrence + Memorial Medical Office Building194 Howard StreetNew London, CT 06320
- Yale Heart and Vascular CenterWawecus Medical Center79 Wawecus StreetNorwich, CT 06360